Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 6,970.00
+310.00 (4.65%)
At close: Aug 20, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 171.86 billion as of August 20, 2026. Its market cap has decreased by -9.62% in one year.
Market Cap
171.86B
Enterprise Value
180.13B
Revenue
15.82B
Ranking
n/a
PE Ratio
246.56
Stock Price
6,970.00
ChartMarket Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 171.86B, a decrease of -21.28%. That is a compound annual growth rate of -2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 171.86B | -10.12% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 256.11B |
| Kangstem Biotech | 242.66B |
| S.Biomedics | 238.91B |
| curacle co.,ltd. | 233.49B |
| Genome & Company | 221.23B |
| Kanaph Therapeutics | 186.18B |
| NIBEC | 180.86B |
| Prestige Biologics | 144.31B |